Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

46.53
+0.23000.50%
Post-market: 46.530.00000.00%19:30 EDT
Volume:165.15K
Turnover:7.66M
Market Cap:1.58B
PE:9.52
High:46.70
Open:46.01
Low:45.76
Close:46.30
52wk High:54.29
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:3.51
T/O Rate:0.60%
Dividend:3.06
Dividend Rate:6.57%
EPS(TTM):4.89
EPS(LYR):2.11
ROE:27.21%
ROA:5.25%
PB:2.36
PE(LYR):22.05

Loading ...

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

GlobeNewswire
·
Jun 16

Global Partners (GLP) Stock Valuation After Earnings Beat And Supportive Fuel Market Conditions

Simply Wall St.
·
Jun 14

Nyse Order Imbalance 6605.0 Shares on Buy Side

THOMSON REUTERS
·
Jun 13

Global GP LLC reports $498,050 purchase of Global Partners common units

Reuters
·
Jun 12

Amgen’s MARITIME-SWITCH Trial Targets GLP-1 Switchers in the Growing Obesity Drug Market

TIPRANKS
·
Jun 12

Employers considering dropping coverage of GLP-1 drugs in 2027, Reuters reports

TIPRANKS
·
Jun 11

How Investors May Respond To Innovent Biologics (SEHK:1801) Advancing Oral And Extended-Interval GLP-1 Candidates

Simply Wall St.
·
Jun 11

Cracker Barrel CEO: GLP-1s Haven't Affected Our Business -- Market Talk

Dow Jones
·
Jun 10

Market Chatter: Ares Management in Talks to Acquire GLP Data Centers

MT Newswires Live
·
Jun 09

AstraZeneca's GLP-1 Pill Clears Early Hurdle in Diabetes, Obesity Tests -- WSJ

Dow Jones
·
Jun 09

Global GP LLC reports $492,900 purchase of Global Partners common units

Reuters
·
Jun 09

Structure Therapeutics Maintained at Buy as Analyst Highlights Best-in-Class Oral GLP-1 Profile and Keeps $145 Price Target Unchanged

TIPRANKS
·
Jun 08

How Phase 2b Oral GLP-1 Data and Phase 3 Plans Will Impact Structure Therapeutics (GPCR) Investors

Simply Wall St.
·
Jun 08

The Wegovy pill is still dominating the GLP-1 pill market

Dow Jones
·
Jun 08

A Look At Global Partners (GLP) Valuation After A Strong Multi Year Return Profile

Simply Wall St.
·
Jun 07

McKesson Buy Rating Reaffirmed as GLP-1 Positioning Supports Outlook; $900 Price Target Maintained

TIPRANKS
·
Jun 05

Americans on GLP-1s Are Overwhelming Retailers With Their Nonstop Returns -- WSJ

Dow Jones
·
Jun 05

New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity

GlobeNewswire
·
Jun 05

Fractyl Health Says One-Year Data Shows Revita Sustains Post-GLP-1 Weight Loss

MT Newswires Live
·
Jun 04

Global GP acquires $737,100 of Global Partners common units

Reuters
·
Jun 04